Insights On Partnering
-
Are Transportation Failures Really Logistics Problems?
6/15/2026
Missed clinical visits stem from fragmented financial workflows — not transport. Integrating payments, approvals, and travel cuts delays, boosts participation, and keeps studies on track.
-
Why Site Training Still Slows Site Activation
5/11/2026
Effective site training relies on clear, accessible, up-to-date materials that reflect real workflows — keeping sites aligned, compliant, and confident throughout the study lifecycle.
-
eCOA Standards And KPIs To Include In Your Next RFI
3/9/2026
Check out this practical roadmap on vendor selection and learn specific performance metrics and quality benchmarks you should ask your next eCOA partner.
-
Why Are Clinical Research Meetings Harder To Plan Right Now?
6/19/2026
Are your clinical meetings setting your study up for success, or creating avoidable challenges? Watch the presentation to learn how to build alignment from the start.
-
Accelerating Recruitment In A Challenging Phase III Rare Disease Trial
8/18/2026
Recruiting for rare acute diseases is challenging. Discover how this organization used rapid site activation and investigator engagement to speed enrollment in a Phase III Anti-GBM trial.
-
5 Myths About Patient Payments In Clinical Trials
10/8/2025
Digital payment solutions debunk myths around clinical trial compensation, improving participant retention, easing site burden, and enabling smoother global operations through faster, more reliable payments.
-
Advancing Oncology Innovation With Adaptive Trial Designs
8/12/2025
When a biopharmaceutical company developing a novel therapy for solid tumor cancers became concerned with rapid over-enrollment from within a single region, they employed a CRO for assistance.
-
Big Futures For Emerging Biopharma: Navigating Biotech Hurdles
1/14/2026
Emerging biopharma drives agile, data-driven, patient-focused drug development. Discover how to overcome complexity, speed timelines, and thrive in a fast-changing healthcare landscape.
-
Reduction Of Screen Failures In A Biomarker
2/24/2026
Targeted prescreening for biomarker and cognitive criteria cut screen failures in a complex Alzheimer’s trial, speeding enrollment and improving site efficiency while maintaining strict eligibility.
-
Mitigating Risk And Complexity In Cell & Gene Therapy Trials With IRT
8/19/2025
CGT pioneers require supply chain partnerships that mitigate trial risk and complexity. Explore how to optimize pre-trial and pre-screening activities and reduce trial cost and risk with an IRT solution.